Mia's Feed
Medical News & Research

Cancer Cells Enhance Energy Production to Survive Mechanical Stress and DNA Damage

Cancer Cells Enhance Energy Production to Survive Mechanical Stress and DNA Damage

Share this article

Scientists discover that cancer cells rapidly boost energy production through mitochondria to survive mechanical stress and repair DNA damage, unveiling new therapeutic targets in tumor invasiveness.

2 min read

Recent research published in Nature Communications reveals that cancer cells rapidly increase their energy output when subjected to physical compression, a common challenge within the tumor microenvironment. This response involves mitochondria, the cell's energy factories, racing to the nucleus surface within seconds to deliver an ATP boost, thereby supporting DNA repair and survival under mechanical stress.

Using advanced microscopy techniques capable of compressing living cells to just three microns wide, scientists at the Center for Genomic Regulation in Barcelona observed that in over 80% of confined HeLa cancer cells, mitochondria form a tight halo around the nucleus, a structure termed "NAMs" or nucleus-associated mitochondria. This mitochondrial halo facilitates an influx of ATP into the nucleus, increasing cellular energy availability. Fluorescent sensors confirmed the surge, with ATP levels elevating approximately 60% within mere seconds of mechanical squeezing.

This energy surge plays a critical role in helping cancer cells adapt to their physically stressful environments, such as squeezing through tiny blood vessels, invading surrounding tissues, or navigating dense tumor tissues. The ability to swiftly boost ATP helps repair DNA damage caused by mechanical forces, keeping the cells viable and proliferating. Notably, analysis of tumor biopsies from patients showed that this NAM signature was more prominent at invasive fronts of tumors, emphasizing its potential relevance in cancer progression.

Further investigations revealed that actin filaments and the endoplasmic reticulum create a scaffold that traps these mitochondria in place around the nucleus. Disrupting actin with specific drugs collapses the NAM structures and diminishes the ATP surge. This insight suggests potential therapeutic targets to hinder cancer cell adaptation — by blocking these scaffolds, it may be possible to reduce tumor invasiveness without damaging normal mitochondrial functions.

Beyond cancer, this mechanical stress response appears to be a fundamental feature in cell biology, applicable to immune cells, neurons, and embryonic cells under physical pressure. Overall, this discovery challenges traditional views of mitochondria as static energy sources, highlighting their dynamic role in cellular adaptation and survival under physical stress.

This pioneering work introduces a new layer of understanding in cell biology and opens avenues for developing treatments that target the mechanical resilience of cancer cells, potentially preventing metastasis and tumor growth.

Stay Updated with Mia's Feed

Get the latest health & wellness insights delivered straight to your inbox.

How often would you like updates?

We respect your privacy. Unsubscribe at any time.

Related Articles

Understanding the Challenges of Mental Health Support for Autistic Individuals

Autistic individuals face higher risks of mental health conditions like anxiety and depression but struggle to access appropriate support due to environmental and systemic barriers. Improvements in training and tailored interventions are essential for better mental health outcomes.

Fascin-1 Protein: A Key Player in Cervical Cancer Spread and Treatment Resistance

New research identifies Fascin-1 as a key driver of cervical cancer progression, metastasis, and treatment resistance, offering promising targets for future therapies.

Common Lung Cancer Symptom Medication May Reduce Effectiveness of Immunotherapy

New research shows that corticosteroids used to manage lung cancer symptoms may reduce the effectiveness of immunotherapy treatments. Learn how steroid use impacts immune response and patient outcomes.

FDA Incorporates AI Technology to Accelerate Drug and Food Safety Assessments

The FDA is leveraging artificial intelligence, including a new tool called Elsa, to accelerate drug and food safety review processes and improve public health outcomes.